PDF RESEARCH VACCINE Neurologic adverse events among 704,003 first-dose recipients of theBNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwidedescriptive study Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study in2me Posted on 4 years ago 1 minute read mainDownload About Author in2me See author's posts Post navigation Previous: A double-blind, placebo-controlled clinical trial of fluvoxamineNext: UK COVID-19 Moderna vaccine analysis print Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related Stories 1 minute read COVID-19 NEWS VACCINE UNITED STATES DISTRICT COURTFOR THE DISTRICT OF COLUMBIA in2me Posted on 3 years ago 0 1 minute read COVID-19 NEWS RESEARCH VIDEO The WHO’s PLANDEMIC: What You Need to Know in2me Posted on 4 years ago 0 1 minute read COVID-19 VACCINE VIDEO Recording of AstraZeneca CEO Pascal Soriot ‘Millions of [Immunocompromised] People Can’t Be Vaxxed’ in2me Posted on 4 years ago 0
